US FDA Approves Second Alzheimer’s Drug That Can Modestly Slow Disease

Source: Time

“U.S. officials have approved another Alzheimer’s drug that can modestly slow the disease, providing a new option for patients in the early stages of the incurable, memory-destroying ailment. The Food and Drug Administration approved Eli Lilly’s Kisunla on Tuesday for mild or early cases of dementia caused by Alzheimer’s. It’s only the second drug that’s been convincingly shown to delay cognitive decline in patients, following last year’s approval of a similar drug from Japanese drugmaker Eisai.” (07/02/24)

https://time.com/6994563/fda-approve-eli-lilly-alzheimers-drug/